Spryng With Osteo Cushion Injectable

Equine joint injectable (osteoarthritis biologic/hyaluronate) for synovitis and joint degeneration management. Equine joint biologic injectable (tiludronate-based or combination product with osteo cushion biologic). Mechanism: bisphosphonate component inhibits osteoclast function → reduces subchondral bone resorption; additional components support synovial membrane and cartilage health. For management of joint inflammation and degenerative joint disease. Key information Tiludronate/chondroitin — equine joint product. For IA use. Refrigerate. Strict aseptic technique. Follow label protocol precisely.

Injectable joint biologic (see bisphosphonate precautions): administer per product-specific protocol, intra-articularly or IV as directed. Aseptic technique for intra-articular. Store at room temperature; protect from light. If a dose is missed This medication is administered by a veterinarian or veterinary staff in a clinical setting. Missed doses are managed by your veterinary team — contact your veterinarian to reschedule.

Bisphosphonate component: GI colic, diarrhea (horses — transient within 24 hrs). Renal: azotemia with dehydration (hydrate before use). Injection site reactions. Transient hypocalcemia post-infusion.

For animals See tiludronate/bisphosphonate precautions. Horses only. Ensure hydration. Not approved for use in food-producing animals. For people handling this medication Administered by veterinary professionals only. No specific human precautions for caregivers beyond normal hygiene.

Contact your veterinarian. Bisphosphonate/chondroitin IA product — overdose managed by veterinary staff.